Recent Finacing
Recent Raise
G1 Therapeutics is a clinical-stage oncology company developing proprietary CDK4/6 small-molecule inhibitors (G1T28, G1T38) and bone-marrow chemoprotectants via a kinase drug-discovery platform, conducting early clinical trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors